Siemens Healthineers has received FDA premarket notification clearance for its blood urea nitrogen and total carbon dioxide point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances.
Read More
MeMed has been awarded a grant from the Department of Defense’s congressionally directed medical research programs to support the transition of its prototype point-of-care platform into a final product.
Read More
Thorne, New York, has introduced five point-of-care health tests for fertility, heavy metals, sleep, stress, and thyroid that measure an individual’s unique biomarkers.
Read More
The BreathID platform has shown positive clinical trial results for detecting clinically significant portal hypertension in nonalcoholic steatohepatitis patients with compensated advanced chronic liver disease.
Read MoreAtomo will supply its AtomoRapid lateral-flow diagnostic platform for use with Access Bio’s in vitro HIV rapid test, which detects the presence of HIV antibodies in a single drop of blood obtained from a fingertip.
Read More